Deep learning for fully automatic detection, segmentation, and Gleason grade estimation of prostate cancer in multiparametric magnetic resonance images.

Journal: Scientific reports
Published Date:

Abstract

Although the emergence of multi-parametric magnetic resonance imaging (mpMRI) has had a profound impact on the diagnosis of prostate cancers (PCa), analyzing these images remains still complex even for experts. This paper proposes a fully automatic system based on Deep Learning that performs localization, segmentation and Gleason grade group (GGG) estimation of PCa lesions from prostate mpMRIs. It uses 490 mpMRIs for training/validation and 75 for testing from two different datasets: ProstateX and Valencian Oncology Institute Foundation. In the test set, it achieves an excellent lesion-level AUC/sensitivity/specificity for the GGG[Formula: see text]2 significance criterion of 0.96/1.00/0.79 for the ProstateX dataset, and 0.95/1.00/0.80 for the IVO dataset. At a patient level, the results are 0.87/1.00/0.375 in ProstateX, and 0.91/1.00/0.762 in IVO. Furthermore, on the online ProstateX grand challenge, the model obtained an AUC of 0.85 (0.87 when trained only on the ProstateX data, tying up with the original winner of the challenge). For expert comparison, IVO radiologist's PI-RADS 4 sensitivity/specificity were 0.88/0.56 at a lesion level, and 0.85/0.58 at a patient level. The full code for the ProstateX-trained model is openly available at https://github.com/OscarPellicer/prostate_lesion_detection . We hope that this will represent a landmark for future research to use, compare and improve upon.

Authors

  • Oscar J Pellicer-Valero
    Intelligent Data Analysis Laboratory, Department of Electronic Engineering, ETSE (Engineering School), Universitat de València (UV), Av. Universitat, sn, 46100, Bujassot, Valencia, Spain. Oscar.Pellicer@uv.es.
  • José L Marenco Jiménez
    Department of Urology, Fundación Instituto Valenciano de Oncología (FIVO), Beltrán Báguena, 8, 46009, Valencia, Spain.
  • Victor Gonzalez-Perez
    Department of Medical Physics, Fundación Instituto, Valenciano de Oncología (FIVO), Beltrán Báguena, 8, 46009, Valencia, Spain.
  • Juan Luis Casanova Ramón-Borja
    Department of Urology, Fundación Instituto Valenciano de Oncología (FIVO), Beltrán Báguena, 8, 46009, Valencia, Spain.
  • Isabel Martín García
    Department of Radiodiagnosis, Fundación Instituto, Valenciano de Oncología (FIVO), Beltrán Báguena, 8, 46009, Valencia, Spain.
  • María Barrios Benito
    Department of Radiodiagnosis, Fundación Instituto, Valenciano de Oncología (FIVO), Beltrán Báguena, 8, 46009, Valencia, Spain.
  • Paula Pelechano Gómez
    Department of Radiodiagnosis, Fundación Instituto, Valenciano de Oncología (FIVO), Beltrán Báguena, 8, 46009, Valencia, Spain.
  • José Rubio-Briones
    Department of Urology, Fundación Instituto Valenciano de Oncología (FIVO), Beltrán Báguena, 8, 46009, Valencia, Spain.
  • María José Rupérez
    Instituto de Ingeniería Mecánica y Biomecánica, Universitat Politècnica de València (UPV), Camino de Vera, sn, 46022, Valencia, Spain.
  • José D Martín-Guerrero
    Intelligent Data Analysis Laboratory, University of Valencia, Av. de la Universidad s/n, 46100 Burjassot (Valencia), Spain.